Adjunctive therapies in the cath lab. Use of combination glycoprotein IIb/IIIa inhibitor and direct thrombin inhibitor drugs to support percutaneous coronary stent placement in a patient with renal insufficiency and heparin-induced thrombocytopenia. [electronic resource]
- The Journal of invasive cardiology Sep 2001
- 657-60 p. digital
Publication Type: Case Reports; Journal Article
1042-3931
Aged Aged, 80 and over Anticoagulants--adverse effects Combined Modality Therapy Coronary Artery Disease--therapy Coronary Thrombosis--drug therapy Drug Therapy, Combination Female Fibrinolytic Agents--therapeutic use Heparin--adverse effects Hirudin Therapy Hirudins--analogs & derivatives Humans Platelet Aggregation Inhibitors--therapeutic use Recombinant Proteins--therapeutic use Renal Insufficiency--complications Stents Thrombocytopenia--chemically induced Tirofiban Tyrosine--analogs & derivatives